Results 71 to 80 of about 13,126 (223)
Box S1. (The history of US Food and Drug Administration’s postmarketing commitments and requirements). Box S2. (Postmarketing commitment reporting requirements). Box S3. (Postmarking commitment categorization). Box S4.
Sanket Dhruva (6846314) +4 more
core +1 more source
Postmarketing Trials and Pediatric Device Approvals
BACKGROUND: Medical devices can be useful in a variety of diseases, but few devices have been specifically approved for use in children. The 2007 Pediatric Medical Device Safety and Improvement Act was passed to stimulate pediatric device development ...
Kesselheim, Aaron +2 more
core +1 more source
Regulatory pathways, study characteristics of pivotal clinical trials, and postmarketing expectations for selected TB, HIV, and HCV NCEs.
Allison LaHood (13149567) +4 more
core +1 more source
Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety
Carlos De las Cuevas,1 Emilio J Sanz,2,3 Jose de Leon4,5 1Department of Internal Medicine, Dermatology, and Psychiatry and Instituto Universitario de Neurociencia (IUNE), Universidad de La Laguna, La Laguna, Canary Islands, Spain; 2Department of Physical
De las Cuevas C, Sanz EJ, de Leon J
doaj
Objectives To compare the premarket and postmarket evidence of safety and efficacy of direct oral anticoagulants approved for stroke prevention in atrial fibrillation patients across four major regulatory agencies.Design Cross-sectional.Setting European ...
Joseph S Ross +2 more
doaj +1 more source
Progress in Natural Products Target Discovery Technology
Here, we provide a comprehensive overview of current technologies and recent advancements in therapeutic target discovery for natural products. By systematically synthesizing the principles, methodologies, and practical applications of existing experimental and computational strategies, this work provides a more actionable reference framework for ...
Qiyuan Pan +7 more
wiley +1 more source
Introduction Considering lack of a European standardized postmarketing food supplement surveillance system (nutrivigilance), some member states and companies have developed their own approaches to monitoring potential adverse reactions (AEs) to secure a ...
Niki Katsiki +9 more
core +1 more source
Forest plot of the odds ratio of OGIB detection in the premarketing and postmarketing settings.
A: Premarketing setting. B: Postmarketing setting.
Mitsuo Umezu (804421) +2 more
core +1 more source
This graphical abstract provides a summary of the analysis of the PACE study that evaluated the effect of high‐concentration capsaicin topical system (HCCTS) on sensory function in patients with DPN. From left to right: Progression of untreated DPN; Research question for current analysis; Outcomes used to evaluate sensory function; Intervention; Main ...
Nathaniel P. Katz +4 more
wiley +1 more source
Post-marketing stability surveillance: Amoxicillin
Background: To ensure the successful treatment of infectious disease using antimicrobial therapy, a sufficient concentration of the stable, active drug is required at the site of infection.
K.K. Naidoo +5 more
doaj +1 more source

